Optifast

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Optifast

Property Description
Active Ingredients Multi-component blend of macronutrients and micronutrients (e.g., Protein, Fat, 27 Vitamins/Minerals)
Form Powder for oral solution, Nutritional bar, Soup mix
Pharmacological Class Very Low-Calorie Diet (VLCD) Formula, Total Meal Replacement (TMR)
Common Use Medically supervised weight management in adults with obesity
Origin Scientifically formulated (Synthetic/Derived); manufactured by Nestlé Health Science

Optifast: Definition and Classification as a Very Low-Calorie Diet (VLCD) Formula

Optifast is a Specialized Medical Food and a Nutritional Formula classified as a Total Meal Replacement (TMR), and it is not a traditional pharmacological drug. It is strictly formulated to meet the requirements of a Very Low-Calorie Diet (VLCD) structure, which is a medically recognized strategy for managing severe weight concerns. VLCDs, generally defined as providing less than 800 kilocalories per day, are intended for clinical use and can lead to rapid initial weight loss. The program, developed and supplied by Nestlé Health Science, is designed for Adults Seeking Structured Weight Loss and typically requires a Physician-Monitored setting due to the intense caloric restriction involved.

Comprehensive Composition and Available Forms

The core of Optifast lies in its precise, Multi-Component composition, which delivers complete nutrition despite the necessary energy restriction. The formula provides high-quality Protein for tissue maintenance, controlled Carbohydrate and Fat, and a comprehensive blend of 27 essential Micronutrients, including Vitamin A, C, D, Biotin, Folic Acid, Calcium, Iron, and Zinc. This measured blend ensures Complete Nutrient Provision while calories are restricted. The product is differentiated by its wide range of Dosage Forms for Oral consumption—including Powder for oral solution (shake mix), Ready-to-drink liquid formula, Nutritional Bar, and Soup Mixes—offering patients necessary variety for adherence during the total meal replacement phase.

The Primary Purpose of Optifast

The primary purpose of Optifast is to achieve significant, controlled Weight Reduction through the principle of Caloric Deficit Induction and Protein Sparing. The structured regimen is Clinically Proven and commonly used for patients with obesity who require substantial weight loss to improve health outcomes like blood glucose and blood pressure control. VLCD programs promote short-term weight loss and are associated with improvements in clinical outcomes. This method is essential for structured Weight Management as it simplifies Calorie Control through complete meal substitution.

What side effects are possible with Optifast?

Possible Side Effects and Safety Information

The safety profile for Optifast, a Very Low-Calorie Diet (VLCD) total meal replacement, is primarily defined by the physiological consequences of rapid weight reduction and severe caloric restriction, as documented by government health authorities like the National Institutes of Health (NIH).

Documented Adverse Reactions and Frequency

Adverse effects are broadly classified by their involvement with specific System-Organ Classes:

  • Gastrointestinal: Common effects include constipation, diarrhea, and flatulence, which are typically associated with the abrupt dietary shift.
  • Nervous System & Systemic: Headache, dizziness, and general fatigue are expected and often more common during the initial adaptation phase of the VLCD program.
  • Metabolism and Nutrition: A state of mild ketosis is an anticipated metabolic effect. However, more serious concerns include the potential for electrolyte imbalance and changes in blood uric acid levels, which necessitates careful clinical observation.

Serious Adverse Reactions and Safety Constraints

The most significant safety constraints relate to the potential for serious adverse reactions that require medical oversight. Gallbladder disease (cholelithiasis), due to rapid weight loss, is a documented risk. Similarly, unmanaged severe electrolyte imbalance can pose serious systemic risks. The VLCD regimen is therefore contraindicated in certain populations, including individuals who are pregnant or breastfeeding, those with recent cardiovascular events, or those with severe renal or hepatic impairment. Consequently, the safety profile is structured around the mandatory requirement for continuous medical monitoring to manage these documented risks and metabolic changes throughout the program's duration.

Overdose and Emergency Response

Optifast Overdose and when to seek help

Optifast is a Very Low-Calorie Diet (VLCD) Formula, and the official regulatory focus regarding overdose pertains to the severe risks of the unsupervised or improperly managed VLCD regimen itself. Since this is not a conventional drug, toxicity is defined by metabolic crisis.

When to Seek Immediate Medical Help

The VLCD approach must be used under Close Medical Supervision in a medically monitored setting. Immediate medical attention is required if signs of severe metabolic distress or cardiac irregularities are observed. Life-threatening outcomes documented in regulatory guidance include Sudden Death by Cardiac Arrest and Ventricular Tachycardia, which often result from rapid, uncorrected Electrolyte Imbalance. Urgent care is necessary to prevent these severe complications.

Documented Manifestations and Management

Transient clinical signs associated with the VLCD state that require monitoring include Fatigue, Headache, Nausea, and Postural Hypotension. The critical procedural step for managing a VLCD-related crisis is Symptomatic and Supportive Treatment, focusing specifically on the Correction of Electrolyte Imbalance. No specific antidote is known for the underlying metabolic disturbances.

Furthermore, official guidance requires the Adjustment of Medication Dosages for any co-prescribed drugs (such as those for hypertension or diabetes) to prevent secondary overdose of those agents as the patient's physiology changes rapidly. The VLCD regimen is officially documented as Not Appropriate for Pregnant or Breastfeeding Women.

Therapeutic Uses of Optifast

What Optifast Treats: Main Uses and Benefits

Optifast is a specialized total meal replacement formula applied in medically supervised programs that supports substantial weight reduction. Its therapeutic benefits may assist in managing significant weight concerns and in the preparatory phase for certain medical procedures. A very low-calorie diet (VLCD) is relevant for individuals with obesity where substantial weight reduction is deemed appropriate.


Addressing Significant Weight and Systemic Imbalance

Optifast is commonly used for adults with clinically significant or morbid obesity where substantial weight reduction is deemed appropriate. The program may be applied in situations where symptoms related to physical discomfort create noticeable physiological strain, contributing to easing the overall symptom burden. It is relevant for managing symptom clusters that create systemic imbalance, including those associated with Metabolic Syndrome, which supports better management of blood sugar and lipid profiles.


Pre-Operative and Clinical Preparation

This structured VLCD approach is commonly used in clinical settings where symptoms associated with acute or episodic changes or metabolic conditions may be a factor during surgery. Optifast is applied in scenarios where additional management of discomfort is required, supporting the patient with pre-operative weight reduction that may assist with preparation for procedures, such as bariatric or certain orthopedic surgeries.


Quick Fact: Support for Systemic Imbalance

Quick Fact: Support for Systemic Imbalance By supporting substantial weight reduction, the program may be part of symptomatic management that contributes to easing the burden of elevated blood pressure and supports better management of blood sugar and lipid profiles.

Eligibility and Restrictions for Use

The Optifast Very Low-Calorie Diet (VLCD) is intended for the dietary management of obesity and is strictly limited to specific populations under medical supervision, as defined by official regulatory protocols.

Category Eligibility Rule (Official Regulatory Status)
Allowed Population Adults with a Body Mass Index (BMI) of 30 or a BMI 27 with coexisting risk factors.
Contraindicated Groups Pregnant women, children under 18 years, and individuals with the metabolic disorder porphyria are strictly contraindicated.
Not Recommended/Unsuitable The Intensive Level is unsuitable for persons over 65 years of age and is not recommended for women who are breastfeeding.
Condition-Based Restrictions Use is not suitable for individuals with severe or advanced renal or liver failure. Patients with a recent myocardial infarction or unstable angina require a cardiologist’s determination of suitability.

The program is only authorized for use under the supervision of a healthcare professional. Precautions must also be taken for users with a history of gallstones, pancreatitis, gout, or severe psychological disturbance.

This framework ensures the VLCD is applied only where the clinical benefits outweigh the risks associated with intense caloric restriction, as defined by authoritative health guidelines.

What should I know about interactions with other medicines?

The official interaction profile for the Optifast Very Low-Calorie Diet (VLCD) formula is governed by two key factors: the metabolic shift induced by the VLCD state and the high mineral content of the formula.

Pharmacodynamic and Metabolic Interactions

The VLCD program's rapid weight loss and caloric restriction may lead to a potentiated risk of hypoglycemia when co-administered with Oral Antidiabetic Agents (e.g., Insulin, Sulfonylureas). Similarly, the VLCD state may produce additive hypotensive effects when co-administered with Antihypertensive Medications (e.g., Diuretics) due to fluid changes.

Exposure-Altering Interactions (Chelation)

The high concentration of divalent and trivalent minerals in the formula can cause reduced systemic exposure of several oral medications by binding to them in the gastrointestinal tract. This absorption interference necessitates timing separation by several hours for agents such as Thyroid Hormones (e.g., Levothyroxine), certain Antibiotics (e.g., Quinolones), and Bisphosphonates.

Restrictions and Procedural Constraints

Official restrictions advise against the use of Alcohol and Excessive Caffeine during the VLCD regimen due to heightened dehydration risk. Furthermore, specific procedural constraints apply to co-administered drugs; for instance, Metformin must be discontinued for a specified duration around the administration of Iodinated Contrast Media.

Mechanism of Action

Caloric Deficit and Metabolic Reprogramming

Optifast works by establishing a sustained and profound energy deficit through its Very Low-Calorie Diet (VLCD) formulation. This deficit compels the body to mobilize stored triglycerides from adipose tissue to serve as the primary fuel source, resulting in the physiological consequence of reduction in fat mass.

Simultaneously, the severe restriction of dietary carbohydrate intake, coupled with the energy deficit, initiates nutritional ketosis. This metabolic shift triggers the liver to increase the production of ketone bodies. These ketones engage central nervous system signaling and exert an anorexigenic effect, which contributes to the modulation of hunger signaling.

Furthermore, the formulation's strategic protein component supports the maintenance of adequate nitrogen balance. This preserves the metabolic process of protein sparing, which minimizes the catabolism of lean body mass (muscle) and contributes to the maintenance of resting metabolic rate.

Dosage and Administration Information

Optifast is an oral nutritional formula used in a structured, multi-level program designed to meet the requirements of a Very Low-Calorie Diet (VLCD). Its administration is strictly categorized by defined phases and controlled caloric dosing.

The program's Intensive Level specifies a daily regimen of three Optifast VLCD products, such as shakes, soups, or bars, consumed as total meal replacements. This dosing is designed to restrict total daily energy intake to 800 kilocalories, which is the criterion for a VLCD. This highly restrictive approach should only be undertaken for a maximum continuous duration of 12 weeks before a planned transition phase begins. Use of the Intensive Level must be conducted under the supervision of a healthcare professional.

Feature Guideline/Rule
Route of administration Oral consumption only.
Dosing schedule Three Optifast VLCD products daily (Intensive Level).
Special procedural conditions Consumption of a minimum of 2 litres of calorie-free fluid per day is mandatory.

The formal instructions establish a highly controlled, time-limited procedural structure for use, commencing with total meal replacement. This schedule dictates the correct frequency and maximum duration for product administration over the course of the overall program.

Recent Clinical Evidence

Research evidence / Overview of studies for Optifast

Evidence for Structured Weight Reduction in Adults with Obesity

The Optifast formula was studied for use in structured weight reduction in adults with obesity. Research examined this approach using Randomized Controlled Trials (RCTs) and Systematic Reviews, which compared the formula's program to other reduced-calorie regimens. These studies included populations defined by higher body mass index (BMI), sometimes including those who also have conditions like Type 2 Diabetes.

Research examined outcomes related to changes in total body weight and body composition (e.g., shifts in fat mass) over a defined period. Findings describe patterns observed in the studies over short-term (several months) and intermediate-term (up to one year) intervals, focusing on the weight change measured during the program's defined phases. Studies monitored how certain metabolic biomarkers (such as blood sugar and blood lipids) evolved in the observed populations, which helps contextualize how metabolic markers were monitored.

However, the long-term effects are not fully established by high-certainty research. Follow-up durations were limited in many studies relative to the chronic nature of weight management. Weight regain following the structured program is a pattern frequently observed in some studies that continued to follow participants. Furthermore, results apply only to the populations studied who were within a highly structured, medically monitored setting.


Evidence for Short-Term Pre-Operative Preparation

Optifast was studied for use in short-term weight reduction in clinical settings, particularly to prepare adult patients for certain major surgeries, such as bariatric procedures. Studies utilized observational settings and short-term RCTs within cohorts of patients preparing for surgery, often exploring the application of the formula during the few weeks immediately before the operation.

The research examined outcomes related to weight change measured in this brief window, as well as changes in internal organ volume (such as liver size). Data show patterns related to the formula's use in relation to short-term pre-operative weight change and liver volume shifts.


Understanding Research Gaps and Limitations

The evidence highlights what is known — and what is still uncertain — about the Optifast formula program. One of the main research limitation frames is that follow-up durations were limited in many trials, which provides only short-term insight into a chronic condition. Additionally, evidence quality varies across studies, and findings concerning the formula's impact on certain surgical outcomes were mixed. Subgroup findings are uncertain due to modest sample sizes in research focusing on specific co-morbidities or demographic groups.

Key Studies & References

  1. Very low energy diets prior to bariatric surgery may reduce postoperative morbidity: a systematic review and meta-analysis of randomized controlled trials (Focus on Pre-Operative Use)
  2. Very Low-Calorie Diets (VLCDs) for obesity fact sheet (Guidance on Structured Programs, Durability, and Population Use)

Frequently Asked Questions (FAQ)

Common questions about Optifast (FAQ)


Q: Is Optifast considered a medication or a diet program?

According to official classification, Optifast is a Specialized Medical Food and a Nutritional Formula designed for total meal replacement. It is strictly formulated to meet the requirements of a Very Low-Calorie Diet (VLCD) structure and is not classified as a traditional pharmacological drug.

Q: What makes Optifast different from a regular low-calorie diet?

The Optifast program utilizes a Very Low-Calorie Diet (VLCD) structure, which is defined as providing le 800 kilocalories per day. This is a much lower caloric level than typically used for a regular low-calorie diet. Official documents describe this difference in caloric level as key to the program's intended mechanism.

Q: What level of carbohydrate restriction is involved in the Optifast VLCD phase?

The Intensive Level of the VLCD program involves a severe restriction of dietary carbohydrate intake to help initiate a metabolic state called ketosis. Official product data indicates that the total daily intake of carbohydrates in this phase is approximately 65 to 68.5 grams.

Q: Does Optifast cause changes in bowel movements?

Yes, regulatory documentation states that common adverse effects associated with the initial, abrupt dietary shift include changes in the digestive system. These most frequently reported effects are constipation, diarrhea, and flatulence.

Q: Does Optifast interact with common blood pressure medicines?

Official clinical protocols indicate that the Very Low-Calorie Diet state can lead to additive hypotensive effects (a lowering of blood pressure) when used alongside Antihypertensive Medications, such as Diuretics. Potential adjustments to medicine dosages are typically managed within the context of medical supervision.

Q: Are there any reported interactions between Optifast and common vitamins?

The official interactions profile notes that the formula's high mineral content can cause reduced systemic exposure of several oral medications by binding to them in the digestive tract. This absorption interference may also affect certain vitamins or supplements, suggesting the timing of ingestion may need to be separated by several hours.

Q: Does Optifast affect blood sugar levels in non-diabetic people?

Research studies into the Optifast program monitor how various metabolic biomarkers evolve in the observed populations. This monitoring includes assessing blood sugar levels in participants both with and without pre-existing Type 2 Diabetes to understand the program’s metabolic effects.

Q: Can you exercise while on the Optifast VLCD phase?

Official program guidelines do not mandate specific exercise requirements during the VLCD phase. While moderate physical activity is generally viewed as beneficial, it is advisable that any physical activity during the program be conducted under the guidance of a healthcare professional.

Q: Do you need a prescription to buy Optifast?

Optifast is classified as a specialized nutritional formula and does not require a prescription for purchase. However, due to the intense caloric restriction involved, official sources note the importance of conducting the VLCD program under the supervision of a healthcare professional.

Q: Is Optifast the same as other meal replacement shakes?

While Optifast products function as total meal replacements (TMRs), the Optifast program is distinguished by its structure as a medically recognized Very Low-Calorie Diet (VLCD). It is designed for use in a controlled, physician-monitored setting, which separates it from general protein or meal replacement shakes.

Q: Can Optifast be used by people with a low BMI?

Official regulatory protocols limit the use of the Optifast VLCD program to Adults with a specific level of obesity, defined as a Body Mass Index (BMI) of ge 30 or a BMI of ge 27 with coexisting risk factors. This indicates the VLCD is not intended for use by people with a low BMI.

Q: What happens in the 'refeeding' or 'maintenance' phase of the Optifast plan?

The structured Optifast program includes a Transition Phase following the Intensive Level, where conventional food is gradually and carefully re-introduced. The final Maintenance Level is designed to support long-term weight management by encouraging three healthy, portion-controlled meals per day.

Q: Do people experience hair loss while on the Optifast diet?

The safety profile documents common adverse reactions related to rapid weight loss, such as dry skin and temporary rash. However, hair loss is not consistently listed in the most common documented adverse reactions provided by official regulatory sources.

Q: Can Optifast affect my sleep patterns?

Studies examining the metabolic effects of Very Low-Calorie Diets and the resulting ketosis have explored changes in sleep. Research suggests that the low carbohydrate content of the VLCD diet has been associated with changes in sleep architecture, including shifts in slow wave and REM sleep patterns.

Q: Can Optifast be used alongside over-the-counter pain relievers?

Clinical protocols advise that certain medications with potent gastrointestinal (GI) side effects, such as non-steroidal anti-inflammatory drugs (NSAIDs), require careful consideration. Using these medicines without food buffering may increase the risk of GI side effects, especially in a VLCD setting.

Q: Is Optifast gluten-free?

According to the official product labeling, many of the Optifast VLCD shake products are designated as Gluten-free. Individuals should always refer to the specific packaging of the product they are consuming, as different product forms may vary in their composition.

Q: Can Optifast be used by people who are lactose intolerant?

Official product composition information states that many Optifast products contain Milk Proteins and are typically classified as Low Lactose. Individuals with lactose intolerance typically seek guidance from a healthcare professional to determine the suitability of specific products.

Q: What types of food can be consumed in addition to the Optifast products?

Official program guidelines for the Intensive Level specify that, in addition to the three Optifast VLCD products, the consumption of at least two cups of low-starch vegetables and one teaspoon of vegetable oil is included in the daily plan. These items are included to provide supplementary nutrition within the program’s caloric structure.

Q: What is the difference between Optifast and standard protein shakes?

Official product classification defines Optifast as a Total Meal Replacement (TMR), meaning it is formulated to deliver complete nutrition, including 27 essential micronutrients, while restricting calories. Standard protein shakes, in contrast, are primarily designed to supplement protein intake and are not balanced for total nutritional replacement.

Q: Can Optifast products be mixed with ingredients other than water?

Preparation instructions generally specify adding the powder to a measured amount of cold or warm water. The program is strictly calorie-controlled to maintain the VLCD criteria, and adding other ingredients is generally restricted to avoid exceeding the defined energy limit.

Q: What is the nutritional breakdown of the Optifast products?

Detailed nutritional data is available on the official product labeling. This information typically covers the total caloric content, the grams of protein, total fat, carbohydrates, fiber, and a complete listing of the 27 essential vitamins and minerals provided by the product.

Q: How does the Optifast VLCD plan manage protein intake?

The formula includes a strategic protein component to help support adequate nitrogen balance in the body. This is crucial for the metabolic process of protein sparing, which minimizes the breakdown of lean body mass, such as muscle tissue, while fat is being mobilized.

Q: Is there a risk of nutritional deficiencies when following the Optifast VLCD plan?

The product is formulated to be nutritionally complete to offset the risk of general deficiencies. However, the safety profile specifically notes the potential for electrolyte imbalance and elevated blood uric acid levels, which are conditions requiring careful clinical observation.

Q: Can men and women use the same Optifast program structure?

The official eligibility rules and program structure are defined for Adults with obesity and do not specify different dosing or caloric restrictions between men and women. The only specified exceptions relate to women who are pregnant or breastfeeding, for whom the program is not recommended or is contraindicated.

Q: Do you gain the weight back after stopping the Optifast program?

Research evidence notes that weight regain following the structured program is a pattern frequently observed in some studies that continued to follow participants over time. This highlights the necessity of transitioning to a long-term maintenance strategy after the VLCD phase is completed.

Q: Can I use Optifast if I have a history of eating disorders?

Official guidelines list a history of severe psychological disturbance as a precaution for using the VLCD. The highly structured and restrictive nature of the diet suggests that individuals with this history typically require specialized guidance from a qualified healthcare professional before beginning the program.

Q: Is Optifast available in different flavors or product forms?

According to official product information, Optifast is available in a variety of Dosage Forms for oral consumption, including powder for oral solution (shake mix), ready-to-drink liquid formula, nutritional bars, and soup mixes. The shakes and other products are available in multiple flavors.

Q: Does Optifast contain caffeine?

Yes, some specific product flavors, such as the Coffee Flavour Shake, are listed in product information as containing caffeine. Furthermore, the overall VLCD plan advises against the consumption of Excessive Caffeine from any source due to the heightened risk of dehydration.

Q: Is Optifast covered by insurance?

The nutritional meal replacements themselves are typically not covered by insurance. However, documentation indicates that certain aspects of the medically monitored program, such as the required provider visits and associated lab work, may be billable to insurance depending on the plan.

Q: What are the typical costs associated with the Optifast program?

Program cost information indicates that the average cost of the meal replacements is typically described as being between 3 and 4 per meal, depending on the specific product form and the location of purchase.

Q: Can people with nut allergies safely use Optifast products?

Official product labeling lists common allergens such as Milk, Soy, and Fish. Individuals with any known allergy, including nut allergies, should consult their healthcare professional to help identify the most suitable products before beginning the program.

Q: Is Optifast a permanent change to diet or a temporary tool?

The Intensive Level of the Optifast program is a time-limited program with a maximum duration of 12 weeks, indicating its use as a temporary tool for structured, short-term weight loss. The program’s longer-term goal relies on the Transition and Maintenance Levels to support a permanent change in eating habits.

Q: How is Optifast classified by major health organizations?

Major health organizations, such as the National Institutes of Health (NIH), classify the Optifast formula as meeting the criteria for a Very Low-Calorie Diet (VLCD). This VLCD classification is a medically recognized and structured strategy for the management of severe weight concerns.

How should Optifast be stored and disposed of?

How to Store and Dispose of Optifast

The storage and disposal requirements for Optifast, a Very Low-Calorie Diet nutritional formula, are based on official product labeling and general health authority guidelines.

Storage Condition Requirement
Temperature and Protection Store in a cool, dry place, protected from excessive heat and moisture, typically below 25 C. Do not freeze liquid formulations.
Container and Stability Keep the container of powder tightly closed after opening. Any mixed or reconstituted product must be consumed immediately or discarded within 4 to 12 hours as specified on the label.
Child Safety The product must be stored out of the sight and reach of children.
Disposal Instructions Unused or expired Optifast should be disposed of using an authorized drug take-back program. If a program is unavailable, follow the regulatory guidance for disposal in household trash by mixing the product with an undesirable substance before sealing and discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Optifast found in:

A-Z Index: